Narrative review: current management and novel targeted therapies in intrahepatic cholangiocarcinoma
Chinese Clinical Oncology · 2023
DOI: 10.21037/cco-22-109 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Chinese Clinical Oncology, 2023. Verfasst von Natalie M Bath und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Surgical Oncology, Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH, USA. Hauptthemen laut MEDLINE: Cholangiocarcinoma, Antineoplastic Agents, Bile Duct Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Surgical Oncology, Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Zitieren
APA
Bath, N. M., & Pawlik, T. M. (2023). Narrative review: current management and novel targeted therapies in intrahepatic cholangiocarcinoma. Chinese Clinical Oncology. https://doi.org/10.21037/cco-22-109
Vancouver
Bath NM, Pawlik TM. Narrative review: current management and novel targeted therapies in intrahepatic cholangiocarcinoma. Chinese Clinical Oncology. 2023. doi:10.21037/cco-22-109
BibTeX
@article{Bath2023,
author = {Bath, Natalie M and Pawlik, Timothy M},
title = {Narrative review: current management and novel targeted therapies in intrahepatic cholangiocarcinoma},
journal = {Chinese Clinical Oncology},
year = {2023},
doi = {10.21037/cco-22-109}
}
EUVIMED